French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 ...

Almirall has completed the decentralized EU regulatory procedure for efinaconazole (Jublia) for onychomycosis. The final step ...

South Korea-based biosimilar drug developer Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) ...

Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...

Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. This strategic ...

Danish CNS specialist Lundbeck today revealed that it has reached to acquire Longboard Pharmaceuticals. Lundbeck said it will ...

Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for ...

UK pharma major GSK today announced positive headline results from two Phase III clinical trials, ANCHOR-1 and ANCHOR-2, ...

French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive ...

A study in *The New England Journal of Medicine* reported seven blood cancer cases in patients treated with bluebird bio's ...

Roche presented positive two-year data from the RAINBOWFISH study on Evrysdi (risdiplam) for spinal muscular atrophy (SMA) in ...

Indian drugmaker Wockhardt’s today announced that the Subject Expert Committee (SEC) of Indian drug regulator, Central Drugs ...